Rebuilding lives and offering hope to people with neurodegenerative diseases (ESL)
Avrion Therapeutics is developing a treatment for amyotrophic lateral sclerosis (ALS), an incurable neurodegenerative disease that leads to death within 3 to 5 years.
In the highly-specialized environment of biotech startups targeting DNA, this EPFL spin-off stands out from the pack for its precision and technological simplicity. Our branding work was driven by a desire to veer from the well-trodden path and shy away from the symbolism used by competitors. All while applying a minimalist visual approach.
We chose to focus on the human being and their life stories rather than focusing directly on technology. Behind each person with the disease is DNA: a life searching for a glimmer of hope that one day they will be able to live a normal life again.
After identifying Aviron’s core values in our brand workshops, we translated them into a strong, consistent brand with significant growth potential.
What if the source of disease can become a source of hope and life?
Avrion Therapeutics specifically targets the non-functional part of DNA and aims to restore it. Mixing a DNA sequence with a calm, smiling symbol seemed like a powerful solution - transmitting the feeling of someone looking at you straight in the eyes, expressing a happier future.
Simultaneously boldly smiling, but also truly pragmatic in its simplicity and visual approach, this brand revolves around humans and recovery.
But also easy to integrate across different media contexts.
